Testosterone therapy for low testosterone with low-risk prostate cancer
Treatments studied
Part of Cancer, Hormones & metabolism, Kidney & urinary clinical trials.
This study tests whether testosterone replacement therapy can safely improve low testosterone symptoms in men with low-risk prostate cancer who are under active surveillance. It aims to see if treatment can help without worsening the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 18 or older.
- You have low-risk prostate cancer and are under active surveillance (your doctor is watching it closely).
- You have had two blood tests showing low testosterone (below 300 ng/dL), taken in the morning.
- You have symptoms of low testosterone, like fatigue or low sex drive.
- You have not used testosterone replacement therapy in the past year.
- You can get the testosterone medication through insurance or pay for it yourself.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving hormone therapy (androgen deprivation therapy) before surgery can improve outcomes for men with high-risk prostate cancer. You will receive a special PSMA PET/CT scan to see how the cancer responds.
This trial tests a short course of hormone therapy (androgen deprivation therapy) for men with a certain type of prostate cancer that is considered high-risk. The goal is to see if a shorter treatment period can still control the cancer while reducing side effects.
This study looks at how testosterone therapy affects blood pressure over 24 hours in men with low testosterone. It may help you understand how this treatment could affect your heart health.
This study tests whether tamoxifen, a pill that blocks estrogen, can help your testosterone levels recover faster after you finish hormone therapy for prostate cancer. It may reduce side effects like fatigue and low sex drive.
This study tests whether watching low-risk prostate cancer closely (instead of treating right away) is safe. It may help some people avoid early treatments and their side effects while still keeping a close eye on the cancer.
This study tests whether curcumin (a supplement made from turmeric) can prevent low-risk prostate cancer from progressing while you stay on active surveillance. If you qualify, you would take curcumin and be monitored closely with regular checkups.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.